Clinical Usefulness of

The role ofA total of 93 patients, including 69 patients with pancreatic NENs and 24 patients with small-intestine NENs, were included. At the time of study entry, 64 patients (68.8%) had PD, and the remaining 29 patients (31.2%) had SD. A total of 62 patients (66.7%) had positiveThe findings of the present study may help physicians dealing with advanced neuroendocrine neoplasms to select patients for whom